NCT06590090 Phase 2 Not yet recruiting
Natrunix in Combination With Methotrexate for Rheumatoid Arthritis Treatment Study sponsor: XBiotech, Inc. · XBIT
Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.
Changes Study details Primary completion 2027-01-15 Estimated
Enrollment · participants 108 Estimated
Source updated 2025-12-09 Last update listed in the registry record
Version history
Changes to this trial Last 12 months Posted 2025-12-09 · 1 field changed
Primary completion date Recorded edit − Previous value 2026-01-15
+ Updated value 2027-01-15
Check registry source This database covers selected trials and recorded edits. Some past edits may be missing, and saved text about the main study measures (endpoints) may be shortened. Check the original registry record when a detail matters. Read our methodology